Abstract |
The Kv1.3 channel-acting scorpion toxins usually adopt the conserved anti-parallel β-sheet domain as the binding interface, but it remains challenging to discover some highly selective Kv1.3 channel-acting toxins. In this work, we investigated the pharmacological profile of the Kv1.3 channel-acting BmKTX-D33H, a structural analogue of the BmKTX scorpion toxin. Interestingly, BmKTX-D33H, with its conserved anti-parallel β-sheet domain as a Kv1.3 channel-interacting interface, exhibited more than 1000-fold selectivity towards the Kv1.3 channel as compared to other K⁺ channels (including Kv1.1, Kv1.2, Kv1.7, Kv11.1, KCa2.2, KCa2.3, and KCa3.1). As expected, BmKTX-D33H was found to inhibit the cytokine production and proliferation of both Jurkat cells and human T cells in vitro. It also significantly improved the delayed-type hypersensitivity (DTH) responses, an autoreactive T cell-mediated inflammation in rats. Amino acid sequence alignment and structural analysis strongly suggest that the "evolutionary" Gly11 residue of BmKTX-D33H interacts with the turret domain of Kv1 channels; it appears to be a pivotal amino acid residue with regard to the selectivity of BmKTX-D33H towards the Kv1.3 channel (in comparison with the highly homologous scorpion toxins). Together, our data indicate that BmKTX-D33H is a Kv1.3 channel-specific blocker. Finally, the remarkable selectivity of BmKTX-D33H highlights the great potential of evolutionary-guided peptide drug design in future studies.
|
Authors | Fang Ye, Youtian Hu, Weiwei Yu, Zili Xie, Jun Hu, Zhijian Cao, Wenxin Li, Yingliang Wu |
Journal | Toxins
(Toxins (Basel))
Vol. 8
Issue 4
Pg. 115
(Apr 19 2016)
ISSN: 2072-6651 [Electronic] Switzerland |
PMID | 27104568
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CD3 Complex
- Cytokines
- Immunologic Factors
- KTX toxin, Buthus
- Kv1.3 Potassium Channel
- Potassium Channel Blockers
- Scorpion Venoms
- Ovalbumin
|
Topics |
- Amino Acid Sequence
- Animals
- Autoimmune Diseases
- CD3 Complex
- Cell Proliferation
(drug effects)
- Cells, Cultured
- Cytokines
(metabolism)
- Female
- HEK293 Cells
- Humans
- Hypersensitivity, Delayed
(chemically induced, drug therapy)
- Immunologic Factors
(chemistry, pharmacology, therapeutic use)
- Jurkat Cells
- Kv1.3 Potassium Channel
(physiology)
- Ovalbumin
- Potassium Channel Blockers
(chemistry, pharmacology, therapeutic use)
- Rats, Inbred Lew
- Scorpion Venoms
(chemistry, pharmacology, therapeutic use)
- Scorpions
- Sequence Alignment
- T-Lymphocytes
(drug effects, metabolism)
|